Search
for
Sort by
Research 61–90 of 1000+
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches
- Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
- Niosomal and ethosomal gels: A comparative in vitro and ex vivo evaluation for repurposing of spironolactone
- Repurposing of Linagliptin Similar FDA Approved Drugs as Antidiabetic Agents
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- A Concept on The Development of The DRDE Series of Compounds for Skin Diseases Using In-Silico ADME And Drug-Likeness Analysis
- Repurposing Metformin for Dermatological Use: Mechanisms, Evidence, and Clinical Perspectives
- Repurposing Finasteride as a quorum sensing inhibitor in Pseudomonas aeruginosa
- Repurposing of H1-receptor antagonists (levo)cetirizine, (des)loratadine, and fexofenadine as a case study for systematic analysis of trials on clinicaltrials.gov using semi-automated processes with custom-coded software
- Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
- Bridging the organoid translational gap: integrating standardization and micropatterning for drug screening in clinical and pharmaceutical medicine
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- African Journal of Biomedical Research
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Repurposed Drugs
- HX17 The fortunate side effect: serendipity and therapeutic innovation in dermatology
- LINCS Dataset-Based Repositioning of Dutasteride as an Anti-Neuroinflammation Agent
- Abstracts
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- The Identification of multi-target Inhibitors of Wolbachia pipientis and Onchocerca volvulus by molecular simulations
- The Identification of multi-target Inhibitors of Wolbachia pipientis and Onchocerca volvulus by molecular simulations
- Effective holistic characterization of small molecule effects using heterogeneous biological networks
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry